312 related articles for article (PubMed ID: 26725321)
21. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
Qin LF; Ng IO
Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
[TBL] [Abstract][Full Text] [Related]
22. Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1.
Kandhi R; Bobbala D; Yeganeh M; Mayhue M; Menendez A; Ilangumaran S
Cytokine; 2016 Jun; 82():58-69. PubMed ID: 26748724
[TBL] [Abstract][Full Text] [Related]
23. The reduction of cell death and proliferation by p27(Kip1) minimizes DNA damage in an experimental model of genotoxicity.
Ranchal I; González R; Bello RI; Ferrín G; Hidalgo AB; Linares CI; Aguilar-Melero P; González-Rubio S; Barrera P; Marchal T; Nakayama KI; de la Mata M; Muntané J
Int J Cancer; 2009 Nov; 125(10):2270-80. PubMed ID: 19672859
[TBL] [Abstract][Full Text] [Related]
24. [Study of cooperation of tumor suppressor p33(ING1b) with p53 gene in hepatocellular carcinoma].
Zhu Z; Lin J; Qu JH; Li FM; Ni CR; Zhu MH
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1795-800. PubMed ID: 14642087
[TBL] [Abstract][Full Text] [Related]
25. Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21(Waf/Cip1) stabilization by activating the ERK1/2-MAPK pathway.
Zhang Y; Liu Y; Duan J; Yan H; Zhang J; Zhang H; Fan Q; Luo F; Yan G; Qiao K; Liu J
Hepatology; 2016 Mar; 63(3):880-97. PubMed ID: 26659654
[TBL] [Abstract][Full Text] [Related]
26. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.
Zhang X; Liu J; Zang D; Wu S; Liu A; Zhu J; Wu G; Li J; Jiang L
Oncotarget; 2015 Jun; 6(17):15180-93. PubMed ID: 25893382
[TBL] [Abstract][Full Text] [Related]
28. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.
Shi YZ; Hui AM; Takayama T; Li X; Cui X; Makuuchi M
Br J Cancer; 2000 Jul; 83(1):50-5. PubMed ID: 10883667
[TBL] [Abstract][Full Text] [Related]
29. miR-155 accelerates proliferation of mouse hepatocytes during liver regeneration by directly targeting SOCS1.
Lin X; Chen L; Li H; Liu Y; Guan Y; Li X; Jia Z; Lin X; Jia J; Sun Y; Xiao D
Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G443-G453. PubMed ID: 29792529
[TBL] [Abstract][Full Text] [Related]
30. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
31. A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes.
Park JS; Qiao L; Gilfor D; Yang MY; Hylemon PB; Benz C; Darlington G; Firestone G; Fisher PB; Dent P
Mol Biol Cell; 2000 Sep; 11(9):2915-32. PubMed ID: 10982390
[TBL] [Abstract][Full Text] [Related]
32. NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
Calvisi DF; Donninger H; Vos MD; Birrer MJ; Gordon L; Leaner V; Clark GJ
Cancer Res; 2009 Jun; 69(11):4629-37. PubMed ID: 19435914
[TBL] [Abstract][Full Text] [Related]
33. Regulation of MET receptor signaling by SOCS1 and its implications for hepatocellular carcinoma.
Gui Y; Yeganeh M; Cepero-Donates Y; Ramanathan S; Saucier C; Ilangumaran S
Curr Pharm Des; 2014; 20(17):2922-33. PubMed ID: 23944359
[TBL] [Abstract][Full Text] [Related]
34. The centrosomal protein Tax1 binding protein 2 is a novel tumor suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2.
Lai WL; Hung WY; Wong LL; Zhou Y; Leong VY; Lee JM; Ng IO; Jin DY; Ching YP
Hepatology; 2012 Nov; 56(5):1770-81. PubMed ID: 22610972
[TBL] [Abstract][Full Text] [Related]
35. Asiatic acid promotes p21(WAF1/CIP1) protein stability through attenuation of NDR1/2 dependent phosphorylation of p21(WAF1/ CIP1) in HepG2 human hepatoma cells.
Chen JY; Chen JY; Xu QW; Xu H; Huang ZH
Asian Pac J Cancer Prev; 2014; 15(2):963-7. PubMed ID: 24568526
[TBL] [Abstract][Full Text] [Related]
36. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic role of p21 in hepatocarcinogenesis suggests a new treatment strategy.
Ohkoshi S; Yano M; Matsuda Y
World J Gastroenterol; 2015 Nov; 21(42):12150-6. PubMed ID: 26576099
[TBL] [Abstract][Full Text] [Related]
38. Decorin deficiency promotes hepatic carcinogenesis.
Horváth Z; Kovalszky I; Fullár A; Kiss K; Schaff Z; Iozzo RV; Baghy K
Matrix Biol; 2014 Apr; 35():194-205. PubMed ID: 24361483
[TBL] [Abstract][Full Text] [Related]
39. Homocysteine inhibits hepatocyte proliferation via endoplasmic reticulum stress.
Yu X; Lv J; Zhu Y; Duan L; Ma L
PLoS One; 2013; 8(1):e54265. PubMed ID: 23349842
[TBL] [Abstract][Full Text] [Related]
40. Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis.
Torisu T; Nakaya M; Watanabe S; Hashimoto M; Yoshida H; Chinen T; Yoshida R; Okamoto F; Hanada T; Torisu K; Takaesu G; Kobayashi T; Yasukawa H; Yoshimura A
Hepatology; 2008 May; 47(5):1644-54. PubMed ID: 18393318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
